Profil
David R.
Seaton served as the Acting CEO, Chief Financial Officer & Secretary at MEI Pharma, Inc. from 2009 to 2010.
Prior to that, he was the Chief Financial Officer at Kazia Therapeutics Ltd.
from 1999 to 2010.
He also served as the Chief Financial Officer & Secretary at Glycotex, Inc. Mr. Seaton received his undergraduate and graduate degrees from The University of New South Wales.
Ehemalige bekannte Positionen von David R. Seaton
Unternehmen | Position | Ende |
---|---|---|
KAZIA THERAPEUTICS LIMITED | Finanzdirektor/CFO | 18.06.2010 |
MEI PHARMA, INC. | Finanzdirektor/CFO | 21.06.2010 |
Glycotex, Inc.
Glycotex, Inc. BiotechnologyHealth Technology Glycotex, Inc. researches and develops drugs. It is a biopharmaceutical company, which focuses on the discovery and development of a novel class drugs for human wound healing and tissue repair. The company discovers the products pertaining to connective tissue repair, skin ulcers, bone fractures and glucan receptor products. Glycotex was founded in May, 1999 and is headquartered in Rockville, MD | Finanzdirektor/CFO | - |
Ausbildung von David R. Seaton
The University of New South Wales | Graduate Degree |
Erfahrungen
Besetzte Positionen
Aktive
Inaktive
Börsennotierte Unternehmen
Private Unternehmen
Beziehungen
Beziehungen ersten Grades
Unternehmen ersten Grades
Herr
Frau
Aufsichtsräte
Führungskräfte
Unternehmensverbindungen
Börsennotierte Unternehmen | 2 |
---|---|
MEI PHARMA, INC. | Health Technology |
KAZIA THERAPEUTICS LIMITED | Health Technology |
Private Unternehmen | 1 |
---|---|
Glycotex, Inc.
Glycotex, Inc. BiotechnologyHealth Technology Glycotex, Inc. researches and develops drugs. It is a biopharmaceutical company, which focuses on the discovery and development of a novel class drugs for human wound healing and tissue repair. The company discovers the products pertaining to connective tissue repair, skin ulcers, bone fractures and glucan receptor products. Glycotex was founded in May, 1999 and is headquartered in Rockville, MD | Health Technology |